Drug Type Small molecule drug |
Synonyms Sitamaquine, Q45, WR 006026 + [3] |
Target- |
Mechanism- |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
Drug Highest PhasePendingPhase 2 |
First Approval Date- |
Regulation- |
Molecular FormulaC21H35Cl2N3O |
InChIKeyAFMFKGVIHLNIEO-UHFFFAOYSA-N |
CAS Registry5330-29-0 |
KEGG | Wiki | ATC | Drug Bank |
---|---|---|---|
- | - | - |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Leishmaniasis, Visceral | Phase 2 | IN | 04 Aug 2006 | |
Leishmaniasis | Phase 2 | - | - | |
Leishmaniasis | Phase 2 | - | - | |
Babesiosis | Preclinical | US | - | - |